Bioethics Check-In: Is SynBio on Track?

<div class="ag87-crtemvc-hsbk"><div class="css-vsf5of"><p class="carina-rte-public-DraftStyleDefault-block"><span style="color: rgb(29,28,29);">As synbio moves closer to industrial scale, the chances of hitting ethical stumbling blocks are likely to increase. From gene editing to biodiversity genetic mining to xenotransplantation, the power of synbio can still lead our best intentions astray. How has synbio done so far as an industry? Have we made major mistakes and if so, have we corrected them or set structures in place to prevent them? What new hurdles should we anticipate and how can we best communicate our goals and needs with policymakers and the public?</span></p></div></div>